IBDEI0PC ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11608,1,4,0)
 ;;=4^R63.2
 ;;^UTILITY(U,$J,358.3,11608,2)
 ;;=^5019540
 ;;^UTILITY(U,$J,358.3,11609,0)
 ;;=R63.3^^68^687^72
 ;;^UTILITY(U,$J,358.3,11609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11609,1,3,0)
 ;;=3^Feeding Difficulties
 ;;^UTILITY(U,$J,358.3,11609,1,4,0)
 ;;=4^R63.3
 ;;^UTILITY(U,$J,358.3,11609,2)
 ;;=^5019541
 ;;^UTILITY(U,$J,358.3,11610,0)
 ;;=R63.4^^68^687^29
 ;;^UTILITY(U,$J,358.3,11610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11610,1,3,0)
 ;;=3^Abnormal Weight Loss
 ;;^UTILITY(U,$J,358.3,11610,1,4,0)
 ;;=4^R63.4
 ;;^UTILITY(U,$J,358.3,11610,2)
 ;;=^5019542
 ;;^UTILITY(U,$J,358.3,11611,0)
 ;;=R63.5^^68^687^28
 ;;^UTILITY(U,$J,358.3,11611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11611,1,3,0)
 ;;=3^Abnormal Weight Gain
 ;;^UTILITY(U,$J,358.3,11611,1,4,0)
 ;;=4^R63.5
 ;;^UTILITY(U,$J,358.3,11611,2)
 ;;=^5019543
 ;;^UTILITY(U,$J,358.3,11612,0)
 ;;=R64.^^68^687^46
 ;;^UTILITY(U,$J,358.3,11612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11612,1,3,0)
 ;;=3^Cachexia
 ;;^UTILITY(U,$J,358.3,11612,1,4,0)
 ;;=4^R64.
 ;;^UTILITY(U,$J,358.3,11612,2)
 ;;=^17920
 ;;^UTILITY(U,$J,358.3,11613,0)
 ;;=R68.3^^68^687^51
 ;;^UTILITY(U,$J,358.3,11613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11613,1,3,0)
 ;;=3^Clubbing of Fingers
 ;;^UTILITY(U,$J,358.3,11613,1,4,0)
 ;;=4^R68.3
 ;;^UTILITY(U,$J,358.3,11613,2)
 ;;=^5019553
 ;;^UTILITY(U,$J,358.3,11614,0)
 ;;=R73.01^^68^687^89
 ;;^UTILITY(U,$J,358.3,11614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11614,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,11614,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,11614,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,11615,0)
 ;;=R73.02^^68^687^90
 ;;^UTILITY(U,$J,358.3,11615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11615,1,3,0)
 ;;=3^Impaired Glucose Tolerance (oral)
 ;;^UTILITY(U,$J,358.3,11615,1,4,0)
 ;;=4^R73.02
 ;;^UTILITY(U,$J,358.3,11615,2)
 ;;=^5019562
 ;;^UTILITY(U,$J,358.3,11616,0)
 ;;=R73.09^^68^687^15
 ;;^UTILITY(U,$J,358.3,11616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11616,1,3,0)
 ;;=3^Abnormal Glucose NEC
 ;;^UTILITY(U,$J,358.3,11616,1,4,0)
 ;;=4^R73.09
 ;;^UTILITY(U,$J,358.3,11616,2)
 ;;=^5019563
 ;;^UTILITY(U,$J,358.3,11617,0)
 ;;=R73.9^^68^687^84
 ;;^UTILITY(U,$J,358.3,11617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11617,1,3,0)
 ;;=3^Hyperglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,11617,1,4,0)
 ;;=4^R73.9
 ;;^UTILITY(U,$J,358.3,11617,2)
 ;;=^5019564
 ;;^UTILITY(U,$J,358.3,11618,0)
 ;;=R76.11^^68^687^142
 ;;^UTILITY(U,$J,358.3,11618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11618,1,3,0)
 ;;=3^Positive PPD
 ;;^UTILITY(U,$J,358.3,11618,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,11618,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,11619,0)
 ;;=R79.1^^68^687^3
 ;;^UTILITY(U,$J,358.3,11619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11619,1,3,0)
 ;;=3^Abnormal Coagulation Profile
 ;;^UTILITY(U,$J,358.3,11619,1,4,0)
 ;;=4^R79.1
 ;;^UTILITY(U,$J,358.3,11619,2)
 ;;=^5019591
 ;;^UTILITY(U,$J,358.3,11620,0)
 ;;=R82.5^^68^687^69
 ;;^UTILITY(U,$J,358.3,11620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11620,1,3,0)
 ;;=3^Elevated Urine Levels of Drug/Meds/Biol Subst
 ;;^UTILITY(U,$J,358.3,11620,1,4,0)
 ;;=4^R82.5
 ;;^UTILITY(U,$J,358.3,11620,2)
 ;;=^5019605
 ;;^UTILITY(U,$J,358.3,11621,0)
 ;;=R82.6^^68^687^26
 ;;^UTILITY(U,$J,358.3,11621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11621,1,3,0)
 ;;=3^Abnormal Urine Levels of Subst of Nonmed Source
 ;;^UTILITY(U,$J,358.3,11621,1,4,0)
 ;;=4^R82.6
 ;;^UTILITY(U,$J,358.3,11621,2)
 ;;=^5019606
 ;;^UTILITY(U,$J,358.3,11622,0)
 ;;=R82.7^^68^687^27
